Chmielowska , E. 2015. Liposomal doxorubicin in first line metastatic HER-2-positive breast cancer for prevention the cardiotoxicity. OncoReview. 5, 1(17) (Mar. 2015), 11-15. DOI:https://doi.org/10.5604/20828691.1147502.